Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Ajax, Chelsea and Hato

ESPN · 18h
Chelsea sign highly rated Ajax defender Jorrel Hato
Chelsea have signed 19-year-old defender Jorrel Hato from Ajax, the club announced on Sunday.
Yahoo Sports · 8h
Chelsea strengthen backline with £37m signing of Ajax’s Jorrel Hato
Chelsea’s £37m Statement of Defensive IntentChelsea’s summer of bold recruitment has taken another decisive step with the £37 million acquisition of Ajax defender Jorrel Hato. The
Outlook India · 14m
Chelsea's Spending Continues As Jorrel Hato Joins From Ajax
Chelsea's summer spending spree has continued with the signing of young defender Jorrel Hato from Ajax. Hato has joined the Blues, who won the Club World Cup last month, in a deal worth £38.6m (€44.2m). The 19-year-old has signed a seven-year deal, keeping him at Chelsea through to the end of the 2031-32 season.
Tribal Football
10h
Hato "very excited" to make Chelsea move: I think I'll be a good fit here
Hato joins Chelsea for a fee of £37m and he has signed a contract to 2032. The 19 year-old said, "I'm very excited, I'm so ...
OneFootball
6h
Ajax Eredivisie 2025/2026 Preview | OneFootball
A special mention should be given to exciting 17-year-old winger Jorthy Mokio. He made 18 appearances for the first team in ...
Naija News
5d
Ajax Lower Jorrel Hato’s Price As Chelsea Talks Advance, Koundé Set To Extend Barca Stay
Ajax have reportedly softened their stance in talks with Chelsea over their defender Jorrel Hato, as the Dutch giants look to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy